Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).Frank A. Sinicrope, Jeffrey A. Meyerhardt, Robert J. Behrens et al.|Journal of Clinical Oncology|2025Cited by 47
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the PancreasLeila T. Tchelebi, Joseph M. Herman, Diana Segovia et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 31